{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:48Z","timestamp":1790371248359,"version":"4.1.0"},"reference-count":102,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japanese Dermatology Association (Shiseido donated)","award":["23K07755"],"award-info":[{"award-number":["23K07755"]}]},{"name":"Scientific Research Grant Committee of the Japan Society for the Promotion of Science","award":["23K07755"],"award-info":[{"award-number":["23K07755"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The skin, the outermost layer of the human body, is exposed to various external stimuli that cause inflammatory skin reactions. These external stimulants trigger external epithelial cell damage and the release of intracellular substances. Following cellular damage or death, intracellular molecules are released that enhance tissue inflammation. As an important substance released from damaged cells, the S100 protein is a low-molecular-weight acidic protein with two calcium-binding sites and EF-hand motif domains. S100 proteins are widely present in systemic organs and interact with other proteins. Recent studies revealed the involvement of S100 in cutaneous inflammatory disorders, psoriasis, and atopic dermatitis. This review provides detailed information on the interactions among various S100 proteins in inflammatory diseases.<\/jats:p>","DOI":"10.3390\/diagnostics13203167","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:14:04Z","timestamp":1696918444000},"page":"3167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis"],"prefix":"10.3390","volume":"13","author":[{"given":"Natsuko","family":"Saito-Sasaki","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","article-title":"The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis","volume":"19","author":"Dainichi","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"623052","DOI":"10.3389\/fimmu.2020.623052","article-title":"Omega 3 fatty acid and skin diseases","volume":"11","author":"Sawada","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: The release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2017.02.027","article-title":"Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice","volume":"140","author":"Honda","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","article-title":"A soluble protein characteristic of the nervous system","volume":"19","author":"Moore","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sugino, H., and Sawada, Y. (2022). Influence of S100A2 in human diseases. Diagnostics, 12.","DOI":"10.3390\/diagnostics12071756"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gonzalez, L.L., Garrie, K., and Turner, M.D. (2020). Role of S100 proteins in health and disease. Biochim. Biophys. Acta Mol. Cell Res., 1867.","DOI":"10.1016\/j.bbamcr.2020.118677"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41598-021-85009-8","article-title":"High S100A2 expression in keratinocytes in patients with drug eruption","volume":"11","author":"Yoshioka","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Xia, T., Qi, C., Du, J., and Ye, C. (2022). High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09180-5"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tashiro, T., and Sawada, Y. (2022). Psoriasis and systemic inflammatory disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084457"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Itamura, M., and Sawada, Y. (2022). Involvement of atopic dermatitis in the development of systemic inflammatory diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113445"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.12.646","article-title":"Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis","volume":"119","author":"Nomura","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2017.10.002","article-title":"Barrier dysfunction in the skin allergy","volume":"67","author":"Egawa","year":"2018","journal-title":"Allergol. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"Rafaels","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2019.06.036","article-title":"Prostaglandin E(2) (PGE(2))-EP2 signaling negatively regulates murine atopic dermatitis-like skin inflammation by suppressing thymic stromal lymphopoietin expression","volume":"144","author":"Sawada","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI7613","article-title":"Overproduction of Th2-specific chemokines in NC\/Nga mice exhibiting atopic dermatitis-like lesions","volume":"104","author":"Vestergaard","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is T(H)2 but also T(H)17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","article-title":"Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: A randomized clinical trial","volume":"157","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1523-1747.2000.00078.x","article-title":"Biochemical characterization of S100A2 in human keratinocytes: Subcellular localization, dimerization, and oxidative cross-linking","volume":"115","author":"Deshpande","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1523-1747.2002.19520.x","article-title":"Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes","volume":"119","author":"Zhang","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00018-006-6256-7","article-title":"Interferon-alpha and transforming growth factor-beta co-induce growth inhibition of human tumor cells","volume":"63","author":"Foser","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/BJ20120014","article-title":"Regulation of S100A2 expression by TGF-\u03b2-induced MEK\/ERK signalling and its role in cell migration\/invasion","volume":"447","author":"Naz","year":"2012","journal-title":"Biochem. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","article-title":"S100A4 and metastasis: A small actor playing many roles","volume":"176","author":"Boye","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1091\/mbc.E17-07-0460","article-title":"S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms","volume":"29","author":"Dulyaninova","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31517","DOI":"10.1074\/jbc.M110.125898","article-title":"Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13","volume":"285","author":"Miranda","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.R500017200","article-title":"S100A4, a mediator of metastasis","volume":"281","author":"Garrett","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Fei, F., Qu, J., Li, C., Wang, X., Li, Y., and Zhang, S. (2017). Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci., 7.","DOI":"10.1186\/s13578-017-0191-1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1091\/mbc.e09-07-0609","article-title":"S100A4 regulates macrophage chemotaxis","volume":"21","author":"Li","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4939-9030-6_22","article-title":"The multifaceted S100A4 protein in cancer and inflammation","volume":"1929","author":"Ambartsumian","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/jid.2009.206","article-title":"Significance of the S100A4 protein in psoriasis","volume":"130","author":"Zibert","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0969-2126(98)00049-5","article-title":"EF-hands at atomic resolution: The structure of human psoriasin (S100A7) solved by MAD phasing","volume":"6","author":"Brodersen","year":"1998","journal-title":"Structure"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"61ra90","DOI":"10.1126\/scitranslmed.3001108","article-title":"Gene from a psoriasis susceptibility locus primes the skin for inflammation","volume":"2","author":"Wolf","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2008.08904.x","article-title":"Detection of psoriasin\/S100A7 in the sera of patients with psoriasis","volume":"160","author":"Anderson","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2015.07.009","article-title":"Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin","volume":"80","author":"Trovato","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.regpep.2011.02.001","article-title":"Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients","volume":"167","author":"Gambichler","year":"2011","journal-title":"Regul. Pept."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Lei, H., Li, X., Jing, B., Xu, H., and Wu, Y. (2017). Human S100A7 induces mature interleukin1\u03b1 expression by RAGE-p38 MAPK-calpain1 pathway in psoriasis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169788"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3892\/ijmm.2016.2718","article-title":"Low vitamin D-modulated calcium-regulating proteins in psoriasis vulgaris plaques: S100A7 overexpression depends on joint involvement","volume":"38","author":"Cubillos","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/exd.13023","article-title":"S100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL-6 secretion through I\u03baB\/NF-\u03baB signalling","volume":"25","author":"Son","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2567.2007.02782.x","article-title":"Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation","volume":"124","author":"Zheng","year":"2008","journal-title":"Immunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/exd.13722","article-title":"The human IL-17A\/F heterodimer regulates psoriasis-associated genes through I\u03baB\u03b6","volume":"27","author":"Bertelsen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/exd.13182","article-title":"IL-17F regulates psoriasis-associated genes through I\u03baB\u03b6","volume":"26","author":"Bertelsen","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1346-8138.15250","article-title":"Interleukin-17A suppresses granular layer formation in a 3-D human epidermis model through regulation of terminal differentiation genes","volume":"47","author":"Sato","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zwicker, S., Hattinger, E., Bureik, D., Batycka-Baran, A., Schmidt, A., Gerber, P.A., Rothenfusser, S., Gilliet, M., Ruzicka, T., and Wolf, R. (2017). Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175153"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2340\/00015555-2960","article-title":"Tofacitinib represses the janus kinase-signal transducer and activators of transcription signalling pathway in keratinocytes","volume":"98","author":"Srivastava","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 Decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jdermsci.2015.05.007","article-title":"Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis","volume":"79","author":"Hattinger","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Hong, Y.J., and Kim, M. (2021). Angiogenesis in chronic inflammatory skin disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222112035"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bjd.14718","article-title":"Psoriasin (S100A7) promotes stress-induced angiogenesis","volume":"175","author":"Vegfors","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/jid.2008.268","article-title":"The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption","volume":"129","author":"Harder","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","article-title":"Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis","volume":"132","author":"Dhingra","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jid.2016.07.027","article-title":"TSLP down-regulates S100A7 and \u00df-defensin 2 via the JAK2\/STAT3-dependent mechanism","volume":"136","author":"Lee","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.jid.2022.01.005","article-title":"TSLP impairs epidermal barrier integrity by stimulating the formation of nuclear IL-33\/phosphorylated STAT3 complex in human keratinocytes","volume":"142","author":"Dai","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.07.013","article-title":"Oral janus kinase\/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","volume":"144","author":"Pavel","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/jid.2009.432","article-title":"Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury","volume":"130","author":"Harder","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/330080a0","article-title":"Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis","volume":"330","author":"Odink","year":"1987","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ouyang, Y., Li, Z., Wang, X., and Ma, J. (2023). S100A8 and S100A9 in cancer. Biochim. Biophys. Acta Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.188891"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jemt.10299","article-title":"S100A9\/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity","volume":"60","author":"Nacken","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2004-02-0446","article-title":"MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes","volume":"104","author":"Vogl","year":"2004","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2133.2006.07198.x","article-title":"Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis","volume":"155","author":"Benoit","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abd.2020.08.008","article-title":"Levels of the interleukins 17A, 22, and 23 and the S100 protein family in the gingival crevicular fluid of psoriatic patients with or without periodontitis","volume":"96","author":"Carvajal","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/03009742.2015.1091497","article-title":"Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity","volume":"45","author":"Bierkarre","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jid.2022.05.1085","article-title":"Association of S100A8\/A9 with lipid-rich necrotic core and treatment with biologic therapy in patients with psoriasis: Results from an observational cohort study","volume":"142","author":"Berg","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"van Velzen, T.J., Stolp, J., van Dam-Nolen, D., Kassem, M., Hendrikse, J., Kooi, M.E., Bos, D., and Nederkoorn, P.J. (2023). Higher leukocyte count is associated with lower presence of carotid lipid-rich necrotic core: A sub-study in the Plaque at RISK (PARISK) study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041370"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e011199","DOI":"10.1161\/CIRCIMAGING.120.011199","article-title":"Treatment of psoriasis with biologic therapy is associated with improvement of coronary artery plaque lipid-rich necrotic core: Results from a prospective, observational study","volume":"13","author":"Choi","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.1000148","article-title":"Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model","volume":"186","author":"Nakajima","year":"2011","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"599947","DOI":"10.3389\/fimmu.2020.599947","article-title":"Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s10753-019-01151-6","article-title":"Tacrolimus inhibits TNF-\u03b1\/IL-17A-produced pro-inflammatory effect on human keratinocytes by regulating I\u03baB\u03b6","volume":"43","author":"Hu","year":"2020","journal-title":"Inflammation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1172\/JCI89867","article-title":"Autoinhibitory regulation of S100A8\/S100A9 alarmin activity locally restricts sterile inflammation","volume":"128","author":"Vogl","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jcb.21639","article-title":"S100A8\/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes","volume":"104","author":"Nukui","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/all.15741","article-title":"Age of onset defines two distinct profiles of atopic dermatitis in adults","volume":"78","author":"Facheris","year":"2023","journal-title":"Allergy"},{"key":"ref_84","first-page":"2476","article-title":"Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes","volume":"20","author":"Kim","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/CCID.S310426","article-title":"Identifying the potential therapeutic targets for atopic dermatitis through the immune infiltration analysis and construction of a ceRNA network","volume":"14","author":"Peng","year":"2021","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/exd.12967","article-title":"Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis","volume":"25","author":"Martel","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/exd.14806","article-title":"Topical emollient prevents the development of atopic dermatitis and atopic march in mice","volume":"32","author":"Zhang","year":"2023","journal-title":"Exp. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1111\/j.1742-4658.2008.06654.x","article-title":"S100-annexin complexes--structural insights","volume":"275","author":"Rezvanpour","year":"2008","journal-title":"FEBS. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.200304017","article-title":"S100C\/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes","volume":"163","author":"Sakaguchi","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"8465083","DOI":"10.1155\/2020\/8465083","article-title":"Alarmins HMGB1, IL-33, S100A7, and S100A12 in psoriasis vulgaris","volume":"2020","author":"Borsky","year":"2020","journal-title":"Mediators. Inflamm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/jdv.13269","article-title":"Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity","volume":"30","author":"Wagenpfeil","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","article-title":"Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis","volume":"42","author":"Foell","year":"2003","journal-title":"Rheumatology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jid.2020.10.012","article-title":"Role of epigenetics in the regulation of immune functions of the skin","volume":"141","author":"Sawada","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"eabe1935","DOI":"10.1126\/sciimmunol.abe1935","article-title":"Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8\/9","volume":"6","author":"Sawada","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jid.2011.348","article-title":"A subset of methylated CpG sites differentiate psoriatic from normal skin","volume":"132","author":"Roberson","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1096\/fj.03-0148fje","article-title":"Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family","volume":"17","author":"Wolf","year":"2003","journal-title":"FASEB J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ced.13370","article-title":"Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis","volume":"43","author":"Awad","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/jid.2011.486","article-title":"Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 \u201calarmins\u201d psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis","volume":"132","author":"Hegyi","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/abd1806-4841.20175038","article-title":"Study of serum levels and skin expression of S100B protein in psoriasis","volume":"92","author":"Salem","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/002215540305100513","article-title":"S100 protein subcellular localization during epidermal differentiation and psoriasis","volume":"51","author":"Broome","year":"2003","journal-title":"J. Histochem. Cytochem."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/20\/3167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:17Z","timestamp":1760130257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/20\/3167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":102,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["diagnostics13203167"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13203167","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}